Home LiteratureArticle Details
PMID: 7474129 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.

Journal of virology ·Vol. 69 ·No. 11 ·1995-11-00 ·Pages 7099-105

Todd BJ, Kedar P, Pope JH

Abstract

Human immunodeficiency virus type 1 (HIV-1) isolates classified as syncytium-inducing (SI) or non-SI (NSI) in the MT-2 T-cell line exhibit characteristic sequence differences in the V1-V2 and V3 regions of the env gene. Seven HIV-1 isolates were phenotyped as NSI or SI in the MT-2 cell line. Unexpectedly, all four NSI viruses induced large syncytia 4 to 8 days postinoculation in a panel of five primary CD4+ T-cell lines (including two clones) generated from the peripheral blood of normal donors by exposure to infectious HIV-1, inactivated HIV-1, or Epstein-Barr virus. The primary T-cell lines yielded neither HIV-1 provirus nor infectious HIV by PCR analysis or exhaustive coculture with phytohemagglutinin-treated blast cells. Three isolates (TC354, PK1, and PK2) were biologically cloned and retained their SI or NSI phenotypes in MT-2 and primary T-cell lines. The biologically cloned provirus DNA was also used to clone and sequence the relevant V2 and V3 regions of the env genes. The amino acid sequences of the V2 and V3 regions were characteristic of patterns already reported for the NSI, switch NSI, and SI phenotypes, respectively. This evidence precludes the possibility that these results were due to contamination of the NSI isolates with SI virus. The results unequivocally indicate that HIV-1 isolates with the NSI genotype and phenotype in MT-2 cells may actively induce syncytia in cloned CD4+ T cells in vitro and support the view that direct cytopathic effects may contribute to the steady decline in CD4+ T cells in asymptomatic HIV-1-seropositive patients without detectable SI virus.

MeSH Terms
Amino Acid Sequence CD4-Positive T-Lymphocytes/virology Cell Line Coculture Techniques Consensus Sequence Flow Cytometry Genotype Giant Cells/cytology,virology HIV Envelope Protein gp120/chemistry,isolation & purification HIV Seronegativity/immunology HIV Seropositivity/immunology,virology HIV-1/genetics,isolation & purification,physiology Herpesvirus 4, Human/pathogenicity Humans Immunophenotyping Kinetics Molecular Sequence Data Phenotype Polymerase Chain Reaction Reference Values Virus Replication
Chemicals
HIV Envelope Protein gp120
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Todd B J
Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Brisbane, Queensland, Australia.
Kedar P
Pope J H
References (31)
31 references, click to expand
  1. Analysis of a human immunodeficiency virus type 1 isolate carrying a truncated transmembrane glycoprotein.
    Virology. 1992 Aug;189(2):534-46 PMID: 1322587
  2. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.
    J Virol. 1992 May;66(5):3183-7 PMID: 1560543
  3. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Ann Intern Med. 1993 May 1;118(9):681-8 PMID: 8096374
  4. Pathogenesis of human immunodeficiency virus infection.
    Microbiol Rev. 1993 Mar;57(1):183-289 PMID: 8464405
  5. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates.
    Science. 1993 Apr 30;260(5108):689-92 PMID: 8097595
  6. Relation of phenotype evolution of HIV-1 to envelope V2 configuration.
    Science. 1993 Jun 4;260(5113):1513-6 PMID: 8502996
  7. The SCID-hu mouse as a model for HIV-1 infection.
    Nature. 1993 Jun 24;363(6431):732-6 PMID: 8515816
  8. Genotypic and phenotypic characterization of HIV-1 patients with primary infection.
    Science. 1993 Aug 27;261(5125):1179-81 PMID: 8356453
  9. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection.
    AIDS. 1993 Aug;7(8):1035-40 PMID: 8104421
  10. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.
    J Infect Dis. 1994 May;169(5):968-74 PMID: 7909549
  11. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop.
    J Virol. 1994 Sep;68(9):5991-6005 PMID: 7545945
  12. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
    Immunol Today. 1994 Jun;15(6):262-8 PMID: 7915115
  13. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.
    J Immunol. 1995 Jan 15;154(2):907-21 PMID: 7814892
  14. Viral dynamics in human immunodeficiency virus type 1 infection.
    Nature. 1995 Jan 12;373(6510):117-22 PMID: 7529365
  15. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Nature. 1995 Jan 12;373(6510):123-6 PMID: 7816094
  16. Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.
    J Virol. 1995 Apr;69(4):2708-15 PMID: 7884929
  17. Sequential determination of viral load and phenotype in human immunodeficiency virus type 1 infection.
    AIDS Res Hum Retroviruses. 1995 Jan;11(1):3-9 PMID: 7734193
  18. How does HIV cause AIDS?
    Science. 1993 May 28;260(5112):1273-9 PMID: 8493571
  19. HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies.
    Int J Cancer. 1984 Feb 15;33(2):239-43 PMID: 6319303
  20. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
    Science. 1984 May 4;224(4648):497-500 PMID: 6200935
  21. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
    Science. 1985 Aug 9;229(4713):563-6 PMID: 2992081
  22. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
    Lancet. 1986 Sep 20;2(8508):660-2 PMID: 2429124
  23. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives.
    J Biol Chem. 1988 Apr 25;263(12):5870-5 PMID: 3258602
  24. The value of MLA 144 culture fluid for the isolation of human immunodeficiency virus.
    Immunol Cell Biol. 1989 Apr;67 ( Pt 2):147-9 PMID: 2471686
  25. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers.
    J Virol. 1990 Feb;64(2):864-72 PMID: 2296085
  26. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
    Cell. 1990 Apr 20;61(2):213-22 PMID: 2331748
  27. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
    J Virol. 1991 Dec;65(12):6931-41 PMID: 1658383
  28. Interleukin-2 enhances production in 24 hours of infectious human immunodeficiency virus type 1 in vitro by naturally infected mononuclear cells from seropositive donors.
    Arch Virol. 1991;121(1-4):227-32 PMID: 1759906
  29. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.
    J Virol. 1992 Mar;66(3):1354-60 PMID: 1738194
  30. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.
    AIDS. 1992 Jan;6(1):49-54 PMID: 1543566
  31. The immunopathogenesis of human immunodeficiency virus infection.
    N Engl J Med. 1993 Feb 4;328(5):327-35 PMID: 8093551
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1995-11-00
Pages
7099-105
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC189629
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]